How The EU Biotech Act Could ‘Level The Playing Field’ For SMEs

 
• By Eliza Slawther
  
SMEs could benefit from improved access to funding and partnerships under the proposed EU Biotech Act (Shutterstock)

More from Interviews

More from Europe